Tides education
Peptide guides.
Understand the research, the evidence gaps and the questions worth asking before considering an emerging treatment.
Tides is a female-led telemedicine clinic founded and medically led by Rachel Deutsch, DNP. These guides explain six compounds discussed in the October 2026 HHS compounding policy. They are educational and do not announce availability through Tides.
BPC-157
Promising laboratory findings do not establish that a particular BPC-157 product will heal an injury or treat digestive disease.
Read the guide → Tissue research and ingredient identityTB-500
Check which molecule was actually studied before applying a wound-healing or recovery claim to TB-500.
Read the guide → Mitochondrial and metabolic researchMOTS-c
Measurements of naturally occurring MOTS-c, animal experiments and studies of an analogue answer different questions from trials of a particular MOTS-c product.
Read the guide → Cellular aging and sleep researchEpitalon
Check the exact substance and the study outcome. Telomerase activity in cells is not the same as improved health or a longer life in people.
Read the guide → Nervous-system researchSemax
The people, condition and formulation studied matter. A neurological study should not become a blanket claim of cognitive enhancement.
Read the guide → Inflammation and digestive researchKPV
An experimental anti-inflammatory effect is a research finding. It does not, by itself, establish a treatment for a person's symptoms.
Read the guide →Policy context
Compounding access and FDA approval
HHS lists all six compounds in an October 2026 enforcement-discretion policy. Its appendix specifies ingredient identities and routes, and the policy sets conditions for covered compounding. The published October 30 notice describes the policy as draft and nonbinding.
A compound appearing in that policy is not an FDA-approved drug, proof of clinical benefit or confirmation that a particular pharmacy product is available. Read the current HHS policy and Appendix B for the original scope and conditions.
Sources checked November 5, 2026. Tides has not announced an online ordering pathway for these six compounds.
How to read a research claim
Start with what was actually studied: a cell model, an animal, a related molecule or a person receiving a particular formulation. Then ask whether the outcome was a laboratory measurement or an improvement that matters to patients. Ingredient identity, route, comparison treatment and follow-up affect what the evidence can support.
More from Tides
About Tides
Female-led telemedicine. Individual clinical care.
Tides was founded and is medically led by Rachel Deutsch, DNP. Treatment requests receive personal clinical review before a prescription is authorized.
Tides provides care in Arizona, California, Colorado, Florida, Illinois, Iowa, Minnesota, Nevada, Oregon, Texas, Utah, Washington. Availability of an individual treatment also depends on clinical and pharmacy requirements.